Alcon independents reject Novartis approach as "grossly inadequate"
21 January 2010
Christopher Spillane
"Unfair, inequitable and offensive" was the verdict of an independent assessment of
Novartis' plans to buy
Alcon. The speciality eye care firm's independent director committee has written to CEO
Daniel Vasella, criticising his attempt to squeeze out Alcon's minority shareholders.
Earlier this...
Please Login to read the full article.
21 January 2010
Christopher Spillane
Earlier this...
Please Login to read the full article.
RELATED CONTENT
EVENTS
28 February 2012
Pestana Chelsea Bridge Hotel London
04 March 2012
The Marriott World Center, Orlando, Florida
26 March 2012
Copenhagen, Denmark
JOB OF THE WEEK
Promote your vacancy here
